Free Trial
NASDAQ:ISPC

iSpecimen Q4 2024 Earnings Report

iSpecimen logo
$0.71 -0.01 (-1.21%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$0.72 +0.00 (+0.66%)
As of 08/29/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

iSpecimen EPS Results

Actual EPS
-$6.28
Consensus EPS
-$4.00
Beat/Miss
Missed by -$2.28
One Year Ago EPS
N/A

iSpecimen Revenue Results

Actual Revenue
$1.48 million
Expected Revenue
$2.98 million
Beat/Miss
Missed by -$1.50 million
YoY Revenue Growth
N/A

iSpecimen Announcement Details

Quarter
Q4 2024
Time
Before Market Opens
Conference Call Date
Monday, April 14, 2025
Conference Call Time
9:30AM ET

Earnings Documents

iSpecimen Earnings Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.tc pixel
See More iSpecimen Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like iSpecimen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on iSpecimen and other key companies, straight to your email.

About iSpecimen

iSpecimen (NASDAQ:ISPC) provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

View iSpecimen Profile

More Earnings Resources from MarketBeat